Dengue virus non-structural protein 1

A pathogenic factor, therapeutic target, and vaccine candidate

Hong Ru Chen, Yen Chung Lai, Trai-Ming Yeh

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Dengue virus (DENV) infection is the most common mosquito-transmitted viral infection. DENV infection can cause mild dengue fever or severe dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Hemorrhage and vascular leakage are two characteristic symptoms of DHF/DSS. However, due to the limited understanding of dengue pathogenesis, no satisfactory therapies to treat nor vaccine to prevent dengue infection are available, and the mortality of DHF/DSS is still high. DENV nonstructural protein 1 (NS1), which can be secreted in patients' sera, has been used as an early diagnostic marker for dengue infection for many years. However, the roles of NS1 in dengue-induced vascular leakage were described only recently. In this article, the pathogenic roles of DENV NS1 in hemorrhage and vascular leakage are reviewed, and the possibility of using NS1 as a therapeutic target and vaccine candidate is discussed.

Original languageEnglish
Article number58
JournalJournal of biomedical science
Volume25
Issue number1
DOIs
Publication statusPublished - 2018 Jul 24

Fingerprint

Viral Structural Proteins
Severe Dengue
Dengue Virus
Viruses
Vaccines
Dengue
Proteins
Virus Diseases
Blood Vessels
Therapeutics
Hemorrhage
Infection
Culicidae

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology
  • Biochemistry, medical
  • Pharmacology (medical)

Cite this

@article{c1d45e87d3de48299b79d05158c12d14,
title = "Dengue virus non-structural protein 1: A pathogenic factor, therapeutic target, and vaccine candidate",
abstract = "Dengue virus (DENV) infection is the most common mosquito-transmitted viral infection. DENV infection can cause mild dengue fever or severe dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Hemorrhage and vascular leakage are two characteristic symptoms of DHF/DSS. However, due to the limited understanding of dengue pathogenesis, no satisfactory therapies to treat nor vaccine to prevent dengue infection are available, and the mortality of DHF/DSS is still high. DENV nonstructural protein 1 (NS1), which can be secreted in patients' sera, has been used as an early diagnostic marker for dengue infection for many years. However, the roles of NS1 in dengue-induced vascular leakage were described only recently. In this article, the pathogenic roles of DENV NS1 in hemorrhage and vascular leakage are reviewed, and the possibility of using NS1 as a therapeutic target and vaccine candidate is discussed.",
author = "Chen, {Hong Ru} and Lai, {Yen Chung} and Trai-Ming Yeh",
year = "2018",
month = "7",
day = "24",
doi = "10.1186/s12929-018-0462-0",
language = "English",
volume = "25",
journal = "Journal of Biomedical Science",
issn = "1021-7770",
publisher = "BioMed Central",
number = "1",

}

Dengue virus non-structural protein 1 : A pathogenic factor, therapeutic target, and vaccine candidate. / Chen, Hong Ru; Lai, Yen Chung; Yeh, Trai-Ming.

In: Journal of biomedical science, Vol. 25, No. 1, 58, 24.07.2018.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Dengue virus non-structural protein 1

T2 - A pathogenic factor, therapeutic target, and vaccine candidate

AU - Chen, Hong Ru

AU - Lai, Yen Chung

AU - Yeh, Trai-Ming

PY - 2018/7/24

Y1 - 2018/7/24

N2 - Dengue virus (DENV) infection is the most common mosquito-transmitted viral infection. DENV infection can cause mild dengue fever or severe dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Hemorrhage and vascular leakage are two characteristic symptoms of DHF/DSS. However, due to the limited understanding of dengue pathogenesis, no satisfactory therapies to treat nor vaccine to prevent dengue infection are available, and the mortality of DHF/DSS is still high. DENV nonstructural protein 1 (NS1), which can be secreted in patients' sera, has been used as an early diagnostic marker for dengue infection for many years. However, the roles of NS1 in dengue-induced vascular leakage were described only recently. In this article, the pathogenic roles of DENV NS1 in hemorrhage and vascular leakage are reviewed, and the possibility of using NS1 as a therapeutic target and vaccine candidate is discussed.

AB - Dengue virus (DENV) infection is the most common mosquito-transmitted viral infection. DENV infection can cause mild dengue fever or severe dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Hemorrhage and vascular leakage are two characteristic symptoms of DHF/DSS. However, due to the limited understanding of dengue pathogenesis, no satisfactory therapies to treat nor vaccine to prevent dengue infection are available, and the mortality of DHF/DSS is still high. DENV nonstructural protein 1 (NS1), which can be secreted in patients' sera, has been used as an early diagnostic marker for dengue infection for many years. However, the roles of NS1 in dengue-induced vascular leakage were described only recently. In this article, the pathogenic roles of DENV NS1 in hemorrhage and vascular leakage are reviewed, and the possibility of using NS1 as a therapeutic target and vaccine candidate is discussed.

UR - http://www.scopus.com/inward/record.url?scp=85050798446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050798446&partnerID=8YFLogxK

U2 - 10.1186/s12929-018-0462-0

DO - 10.1186/s12929-018-0462-0

M3 - Review article

VL - 25

JO - Journal of Biomedical Science

JF - Journal of Biomedical Science

SN - 1021-7770

IS - 1

M1 - 58

ER -